share_log

4: Statement of changes in beneficial ownership of securities-Officer Dogan Meeshanthini

SEC ·  Sep 9, 2024 23:05

Summary by Futu AI

Cardio Diagnostics Holdings, Inc. CEO Dogan Meeshanthini completed a purchase of company stock on September 6, 2024. The transaction involved the acquisition of 68,965 shares of common stock at a price of $0.29 per share. Following this transaction, Meeshanthini's direct holdings in the company increased to a total of 1,683,867 shares. The transaction, which took place in the open market, reflects the CEO's direct investment in the company's equity.
Cardio Diagnostics Holdings, Inc. CEO Dogan Meeshanthini completed a purchase of company stock on September 6, 2024. The transaction involved the acquisition of 68,965 shares of common stock at a price of $0.29 per share. Following this transaction, Meeshanthini's direct holdings in the company increased to a total of 1,683,867 shares. The transaction, which took place in the open market, reflects the CEO's direct investment in the company's equity.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Related Stocks Related Stocks
    Symbol Mini Chart Price
    Syros Pharmaceuticals
    SYRS
    -- 0.0995
    LEXARIA BIOSCIENCE CORP C/WTS(TO PUR COM)
    LEXXW
    -- 0.2600
    CNS Pharmaceuticals
    CNSP
    -- 3.1469
    Anebulo Pharmaceuticals
    ANEB
    -- 1.640
    CervoMed
    CRVO
    -- 6.627
    Log In for the Full List
    Investment Course
    Choose stocks based on financial reports
    Quickly master financial season learning guidelines
    When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
    [2025.2] How should NVIDIA's performance be viewed? The key indicator to watch for short-term stock prices is this.
    NVIDIA has been one of the best-performing Technology giants in the US stock market over the past two years, and since 2024, its stock price has experienced sig
    How to view Tesla's performance in January 2025? Pay attention to these four key points.
    It's earnings season for US stocks again. The performance of giant companies not only affects their own stock prices but also influences the overall trend of th